Developmental changes in the transcriptome of the rat choroid plexus in relation to neuroprotection

Springer Science and Business Media LLC - 2013
Ingrid Kratzer1, Shane A. Liddelow2, NR Saunders2, Katarzyna Dziegielewska2, Nathalie Strazielle1, Jean-François Ghersi-Egea1
1Inserm U1028, Lyon Neuroscience Research Center, Neurooncology & Neuroinflammation Team, Lyon-1 University, F-69000, Lyon, France
2Department of Pharmacology & Therapeutics, University of Melbourne,Victoria, 3010, Parkville, Australia

Tóm tắt

Abstract Background The choroid plexuses are the interface between the blood and the cerebrospinal fluid (CSF) contained within the ventricular spaces of the central nervous system. The tight junctions linking adjacent cells of the choroidal epithelium create a physical barrier to paracellular movement of molecules. Multispecific efflux transporters as well as drug-metabolizing and antioxidant enzymes functioning in these cells contribute to a metabolic barrier. These barrier properties reflect a neuroprotective function of the choroid plexus. The choroid plexuses develop early during embryogenesis and provide pivotal control of the internal environment throughout development when the brain is especially vulnerable to toxic insults. Perinatal injuries like hypoxia and trauma, and exposure to drugs or toxic xenobiotics can have serious consequences on neurogenesis and long-term development. The present study describes the developmental expression pattern of genes involved in the neuroprotective functions of the blood–CSF barrier. Methods The transcriptome of rat lateral ventricular choroid plexuses isolated from fifteen-day-old embryos, nineteen-day old fetuses, two-day old pups, and adults was analyzed by a combination of Affymetrix microarrays, Illumina RNA-Sequencing, and quantitative RT-PCR. Results Genes coding for proteins involved in junction formation are expressed early during development. Overall perinatal expression levels of genes involved in drug metabolism and antioxidant mechanisms are similar to, or higher than levels measured in adults. A similar developmental pattern was observed for multispecific efflux transporter genes of the Abc and Slc superfamilies. Expression of all these genes was more variable in choroid plexus from fifteen-day-old embryos. A large panel of transcription factors involved in the xenobiotic- or cell stress-mediated induction of detoxifying enzymes and transporters is also expressed throughout development. Conclusions This transcriptomic analysis suggests relatively well–established neuroprotective mechanisms at the blood-CSF barrier throughout development of the rat. The expression of many transcription factors early in development raises the possibility of additional protection for the vulnerable developing brain, should the fetus or newborn be exposed to drugs or other xenobiotics.

Từ khóa


Tài liệu tham khảo

Dziegielewska KM, Ek J, Habgood MD, Saunders NR: Development of the choroid plexus. Microsc Res Tech. 2001, 52: 5-20. 10.1002/1097-0029(20010101)52:1<5::AID-JEMT3>3.0.CO;2-J.

Shuangshoti S, Netsky MG: Choroid plexus and paraphysis in lower vertebrates. J Morphol. 1966, 120: 157-187. 10.1002/jmor.1051200204.

Strazielle N, Ghersi-Egea JF: Choroid plexus in the central nervous system: biology and physiopathology. J Neuropathol Exp Neurol. 2000, 59: 561-574.

Liddelow SA, Temple S, Mollgard K, Gehwolf R, Wagner A, Bauer H, Bauer HC, Phoenix TN, Dziegielewska KM, Saunders NR: Molecular characterisation of transport mechanisms at the developing mouse blood-CSF interface: a transcriptome approach. PLoS One. 2012, 7: e33554-10.1371/journal.pone.0033554.

Damkier HH, Praetorius J: Genetic ablation of Slc4a10 alters the expression pattern of transporters involved in solute movement in the mouse choroid plexus. Am J Physiol Cell Physiol. 2012, 302: C1452-C1459. 10.1152/ajpcell.00285.2011.

Catala M: Embryonic and fetal development of structures associated with the cerebro-spinal fluid in man and other species. Part I: The ventricular system, meninges and choroid plexuses. Arch Anat Cytol Pathol. 1998, 46: 153-169.

Johansson PA, Dziegielewska KM, Liddelow SA, Saunders NR: The blood-CSF barrier explained: when development is not immaturity. BioEssays. 2008, 30: 237-248. 10.1002/bies.20718.

Strazielle N, Ghersi-Egea JF: Physiology of blood–brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol Pharm. 2013, 10: 1473-1491. 10.1021/mp300518e.

Brightman MW, Reese TS: Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol. 1969, 40: 648-677. 10.1083/jcb.40.3.648.

Mollgard K, Malinowska DH, Saunders NR: Lack of correlation between tight junction morphology and permeability properties in developping choroid plexus. Nature. 1976, 264: 293-294. 10.1038/264293a0.

Wolburg H, Wolburg-Buchholz K, Liebner S, Engelhardt B: Claudin-1, claudin-2 and claudin-11 are present in tight junctions of choroid plexus epithelium of the mouse. Neurosci Lett. 2001, 307: 77-80. 10.1016/S0304-3940(01)01927-9.

Johansson PA, Dziegielewska KM, Ek CJ, Habgood MD, Liddelow SA, Potter AM, Stolp HB, Saunders NR: Blood-CSF barrier function in the rat embryo. Eur J Neurosci. 2006, 24: 65-76. 10.1111/j.1460-9568.2006.04904.x.

Ek CJ, Dziegielewska KM, Stolp H, Saunders NR: Functional effectiveness of the blood–brain barrier to small water-soluble molecules in developing and adult opossum (Monodelphis domestica). J Comp Neurol. 2006, 496: 13-26. 10.1002/cne.20885.

Ek CJ, Habgood MD, Dziegielewska KM, Saunders NR: Structural characteristics and barrier properties of the choroid plexuses in developing brain of the opossum (Monodelphis Domestica). J Comp Neurol. 2003, 460: 451-464. 10.1002/cne.10661.

Kratzer I, Vasiljevic A, Rey C, Fevre-Montange M, Saunders N, Strazielle N, Ghersi-Egea JF: Complexity and developmental changes in the expression pattern of claudins at the blood-CSF barrier. Histochem Cell Biol. 2012, 138: 861-879. 10.1007/s00418-012-1001-9.

Wijnholds J, DeLange EC, Scheffer GL, Van Den Berg DJ, Mol CA, Van Der Valk M, Schinkel AH, Scheper RJ, Breimer DD, Borst P: Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest. 2000, 105: 279-285. 10.1172/JCI8267.

Leggas M, Adachi M, Scheffer GL, Sun D, Wielinga P, Du G, Mercer KE, Zhuang Y, Panetta JC, Johnston B: Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol. 2004, 24: 7612-7621. 10.1128/MCB.24.17.7612-7621.2004.

Kusuhara H, Sugiyama Y: Efflux transport systems for organic anions and cations at the blood-CSF barrier. Adv Drug Deliv Rev. 2004, 56: 1741-1763. 10.1016/j.addr.2004.07.007.

Nagata Y, Kusuhara H, Endou H, Sugiyama Y: Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus. Mol Pharmacol. 2002, 61: 982-988. 10.1124/mol.61.5.982.

Smith DE, Hu Y, Shen H, Nagaraja TN, Fenstermacher JD, Keep RF: Distribution of glycylsarcosine and cefadroxil among cerebrospinal fluid, choroid plexus, and brain parenchyma after intracerebroventricular injection is markedly different between wild-type and Pept2 null mice. J Cereb Blood Flow Metab. 2011, 31: 250-261. 10.1038/jcbfm.2010.84.

Strazielle N, Khuth ST, Ghersi-Egea JF: Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations. Adv Drug Deliv Rev. 2004, 56: 1717-1740. 10.1016/j.addr.2004.07.006.

Strazielle N, Ghersi-Egea JF: Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics. J Neurosci. 1999, 19: 6275-6289.

Ghersi-Egea JF, Strazielle N, Murat A, Jouvet A, Buenerd A, Belin MF: Brain protection at the blood-cerebrospinal fluid interface involves a glutathione-dependent metabolic barrier mechanism. J Cereb Blood Flow Metab. 2006, 26: 1165-1175.

Ek CJ, Wong A, Liddelow SA, Johansson PA, Dziegielewska KM, Saunders NR: Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat. Toxicol Lett. 2010, 197: 51-59. 10.1016/j.toxlet.2010.04.025.

Gazzin S, Strazielle N, Schmitt C, Fevre-Montange M, Ostrow JD, Tiribelli C, Ghersi-Egea JF: Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood–brain interfaces. J Comp Neurol. 2008, 510: 497-507. 10.1002/cne.21808.

Daood M, Tsai C, Ahdab-Barmada M, Watchko JF: ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics. 2008, 39: 211-218. 10.1055/s-0028-1103272.

Richard K, Hume R, Kaptein E, Stanley EL, Visser TJ, Coughtrie MW: Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J Clin Endocrinol Metab. 2001, 86: 2734-2742. 10.1210/jc.86.6.2734.

Stolp HB, Turnquist C, Dziegielewska KM, Saunders NR, Anthony DC, Molnar Z: Reduced ventricular proliferation in the foetal cortex following maternal inflammation in the mouse. Brain. 2011, 134: 3236-3248. 10.1093/brain/awr237.

Aleksunes LM, Klaassen CD: Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARalpha-, and Nrf2-null mice. Drug Metab Dispos. 2012, 40: 1366-1379. 10.1124/dmd.112.045112.

Higgins LG, Hayes JD: Mechanisms of induction of cytosolic and microsomal glutathione transferase (GST) genes by xenobiotics and pro-inflammatory agents. Drug Metab Rev. 2011, 43: 92-137. 10.3109/03602532.2011.567391.

Okada K, Shoda J, Taguchi K, Maher JM, Ishizaki K, Inoue Y, Ohtsuki M, Goto N, Sugimoto H, Utsunomiya H: Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems. Biochem Biophys Res Commun. 2009, 389: 431-436. 10.1016/j.bbrc.2009.08.156.

Strazielle N, Ghersi-Egea JF: Drug metabolism in newborn rat choroid plexus from lateral, third and fourth ventricle. Dev Anim Vet Sci. 1997, 27: 895-901.

Saunders NR, Ek CJ, Habgood MD, Johansson P, Liddelow S, Dziegielewska KM: Assessing blood-cerebrospinal fluid barrier permeability in the rat embryo. Methods Mol Biol. 2011, 686: 247-265. 10.1007/978-1-60761-938-3_11.

Liddelow S, Dziegielewska KM, Ek CJ, Habgood MD, Bauer H, Bauer H-C, Lindsay H, Wakefield MJ, Strazielle N, Kratzer I: Mechanisms that determine the internal environment of the developing brain: a transcriptomic, functional and ultrastructural approach. PLoS One. 2013, 8: e65629-10.1371/journal.pone.0065629.

Fang Z, Cui X: Design and validation issues in RNA-seq experiments. Brief Bioinform. 2011, 12: 280-287. 10.1093/bib/bbr004.

Griffith M, Griffith OL, Mwenifumbo J, Goya R, Morrissy AS, Morin RD, Corbett R, Tang MJ, Hou YC, Pugh TJ: Alternative expression analysis by RNA sequencing. Nat Methods. 2010, 7: 843-847. 10.1038/nmeth.1503.

Bottomly D, Walter NA, Hunter JE, Darakjian P, Kawane S, Buck KJ, Searles RP, Mooney M, McWeeney SK, Hitzemann R: Evaluating gene expression in C57BL/6J and DBA/2J mouse striatum using RNA-Seq and microarrays. PLoS One. 2011, 6: e17820-10.1371/journal.pone.0017820.

Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y: RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res. 2008, 18: 1509-1517. 10.1101/gr.079558.108.

Leslie EM, Deeley RG, Cole SP: Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol. 2005, 204: 216-237. 10.1016/j.taap.2004.10.012.

Redzic ZB, Malatiali SA, Grujicic D, Isakovic AJ: Expression and functional activity of nucleoside transporters in human choroid plexus. Cerebrospinal Fluid Res. 2010, 7: 2-10.1186/1743-8454-7-2.

Choudhuri S, Cherrington NJ, Li N, Klaassen CD: Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug Metab Dispos. 2003, 31: 1337-1345. 10.1124/dmd.31.11.1337.

Hoque MT, Robillard KR, Bendayan R: Regulation of breast cancer resistant protein by peroxisome proliferator-activated receptor alpha in human brain microvessel endothelial cells. Mol Pharmacol. 2012, 81: 598-609. 10.1124/mol.111.076745.

Hagenbuch B, Meier PJ: The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta. 2003, 1609: 1-18. 10.1016/S0005-2736(02)00633-8.

Ohtsuki S, Takizawa T, Takanaga H, Terasaki N, Kitazawa T, Sasaki M, Abe T, Hosoya K, Terasaki T: In vitro study of the functional expression of organic anion transporting polypeptide 3 at rat choroid plexus epithelial cells and its involvement in the cerebrospinal fluid-to-blood transport of estrone-3-sulfate. Mol Pharmacol. 2003, 63: 532-537. 10.1124/mol.63.3.532.

Abe T, Kakyo M, Sakagami H, Tokui T, Nishio T, Tanemoto M, Nomura H, Hebert SC, Matsuno S, Kondo H: Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. J Biol Chem. 1998, 273: 22395-22401. 10.1074/jbc.273.35.22395.

Gao B, Stieger B, Noe B, Fritschy JM, Meier PJ: Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain. J Histochem Cytochem. 1999, 47: 1255-1264. 10.1177/002215549904701005.

Roth M, Obaidat A, Hagenbuch B: OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol. 2012, 165: 1260-1287. 10.1111/j.1476-5381.2011.01724.x.

Berbel P, Navarro D, Auso E, Varea E, Rodriguez AE, Ballesta JJ, Salinas M, Flores E, Faura CC, de Escobar GM: Role of late maternal thyroid hormones in cerebral cortex development: an experimental model for human prematurity. Cereb Cortex. 2010, 20: 1462-1475. 10.1093/cercor/bhp212.

Sugiyama D, Kusuhara H, Taniguchi H, Ishikawa S, Nozaki Y, Aburatani H, Sugiyama Y: Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood–brain barrier: high affinity transporter for thyroxine. J Biol Chem. 2003, 278: 43489-43495. 10.1074/jbc.M306933200.

Morreale De Escobar G, Obregon MJ, Escobar Del Rey F: Role of thyroid hormone during early brain development. Eur J Endocrinol. 2004, 151 (3): 25-37.

Huber RD, Gao B, Sidler Pfandler MA, Zhang-Fu W, Leuthold S, Hagenbuch B, Folkers G, Meier PJ, Stieger B: Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain. Am J Physiol Cell Physiol. 2007, 292: 795-806.

Fung WP, Thomas T, Dickson PW, Aldred AR, Milland J, Dziadek M, Power B, Hudson P, Schreiber G: Structure and expression of the rat transthyretin (prealbumin) gene. J Biol Chem. 1988, 263: 480-488.

Monk JA, Sims NA, Dziegielewska KM, Weiss RE, Ramsay RG, Richardson SJ: Delayed development of specific thyroid hormone-regulated events in transthyretin null mice. Am J Physiol Endocrinol Metab. 2013, 304: E23-E31. 10.1152/ajpendo.00216.2012.

Jacobsson JA, Haitina T, Lindblom J, Fredriksson R: Identification of six putative human transporters with structural similarity to the drug transporter SLC22 family. Genomics. 2007, 90: 595-609. 10.1016/j.ygeno.2007.03.017.

Tamai I: Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21). Biopharm Drug Dispos. 2013, 34: 29-44. 10.1002/bdd.1816.

Pritchard JB, Sweet DH, Miller DS, Walden R: Mechanism of organic anion transport across the apical membrane of choroid plexus. J Biol Chem. 1999, 274: 33382-33387. 10.1074/jbc.274.47.33382.

Strazielle N, Belin MF, Ghersi-Egea JF: Choroid plexus controls brain availability of anti-HIV nucleoside analogs via pharmacologically inhibitable organic anion transporters. AIDS. 2003, 17: 1473-1485. 10.1097/00002030-200307040-00008.

Burckhardt G: Drug transport by Organic Anion Transporters (OATs). Pharmacol Ther. 2012, 136: 106-130. 10.1016/j.pharmthera.2012.07.010.

Nehlig A, de Pereirax Vasconcelos A: Glucose and ketone body utilization by the brain of neonatal rats. Prog Neurobiol. 1993, 40: 163-221. 10.1016/0301-0082(93)90022-K.

Rauchova H, Vokurkova M, Koudelova J: Hypoxia-induced lipid peroxidation in the brain during postnatal ontogenesis. Physiol Res. 2012, 61 (Suppl 1): S89-S101.

Ayala CA: Stimulation of choline acetyl transferase activity by L-carnitine and D-carnitine in brain areas of neonate rats. J Neurosci Res. 1995, 41: 403-408. 10.1002/jnr.490410313.

Bennett KM, Liu J, Hoelting C, Stoll J: Expression and analysis of two novel rat organic cation transporter homologs, SLC22A17 and SLC22A23. Mol Cell Biochem. 2011, 352: 143-154. 10.1007/s11010-011-0748-y.

Gupta K, Shukla M, Cowland JB, Malemud CJ, Haqqi TM: Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9. Arthritis Rheum. 2007, 56: 3326-3335. 10.1002/art.22879.

Strazielle N, Khuth ST, Murat A, Chalon A, Giraudon P, Belin MF, Ghersi-Egea JF: Pro-inflammatory cytokines modulate matrix metalloproteinase secretion and organic anion transport at the blood-cerebrospinal fluid barrier. J Neuropathol Exp Neurol. 2003, 62: 1254-1264.

Ip JP, Nocon AL, Hofer MJ, Lim SL, Muller M, Campbell IL: Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration. J Neuroinflammation. 2011, 8: 124-10.1186/1742-2094-8-124.

Keep RF, Smith DE: Choroid plexus transport: gene deletion studies. Fluids Barriers CNS. 2011, 8: 26-10.1186/2045-8118-8-26.

Shu C, Shen H, Teuscher NS, Lorenzi PJ, Keep RF, Smith DE: Role of PEPT2 in peptide/mimetic trafficking at the blood-cerebrospinal fluid barrier: studies in rat choroid plexus epithelial cells in primary culture. J Pharmacol Exp Ther. 2002, 301: 820-829. 10.1124/jpet.301.3.820.

Mackey JR, Mani RS, Selner M, Mowles D, Young JD, Belt JA, Crawford CR, Cass CE: Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res. 1998, 58: 4349-4357.

Redzic ZB, Biringer J, Barnes K, Baldwin SA, Al-Sarraf H, Nicola PA, Young JD, Cass CE, Barrand MA, Hladky SB: Polarized distribution of nucleoside transporters in rat brain endothelial and choroid plexus epithelial cells. J Neurochem. 2005, 94: 1420-1426. 10.1111/j.1471-4159.2005.03312.x.

Ghersi-Egea JF, Leninger-Muller B, Suleman G, Siest G, Minn A: Localization of drug-metabolizing enzyme activities to blood–brain interfaces and circumventricular organs. J Neurochem. 1994, 62: 1089-1096.

Brittebo EB: Metabolism-dependent binding of the heterocyclic amine Trp-P-1 in endothelial cells of choroid plexus and in large cerebral veins of cytochrome P450-induced mice. Brain Res. 1994, 659: 91-98. 10.1016/0006-8993(94)90867-2.

Morse DC, Stein AP, Thomas PE, Lowndes HE: Distribution and induction of cytochrome P450 1A1 and 1A2 in rat brain. Toxicol Appl Pharmacol. 1998, 152: 232-239. 10.1006/taap.1998.8477.

Granberg L, Ostergren A, Brandt I, Brittebo EB: CYP1A1 and CYP1B1 in blood–brain interfaces: CYP1A1-dependent bioactivation of 7,12-dimethylbenz(a)anthracene in endothelial cells. Drug Metab Dispos. 2003, 31: 259-265. 10.1124/dmd.31.3.259.

Dauchy S, Miller F, Couraud PO, Weaver RJ, Weksler B, Romero IA, Scherrmann JM, De Waziers I, Decleves X: Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem Pharmacol. 2009, 77: 897-909. 10.1016/j.bcp.2008.11.001.

Marowsky A, Burgener J, Falck JR, Fritschy JM, Arand M: Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism. Neuroscience. 2009, 163: 646-661. 10.1016/j.neuroscience.2009.06.033.

Janmohamed A, Hernandez D, Phillips IR, Shephard EA: Cell-, tissue-, sex- and developmental stage-specific expression of mouse flavin-containing monooxygenases (Fmos). Biochem Pharmacol. 2004, 68: 73-83. 10.1016/j.bcp.2004.02.036.

Gazzin S, Strazielle N, Tiribelli C, Ghersi-Egea JF: Transport and metabolism at blood–brain interfaces and in neural cells: relevance to bilirubin-induced encephalopathy. Front Pharmacol. 2012, 3: 89-

Jakobsson PJ, Scoggan KA, Yergey J, Mancini JA, Ford-Hutchinson AW: Characterization of microsomal GST-II by western blot and identification of a novel LTC4 isomer. J Lipid Mediat Cell Signal. 1997, 17: 15-19. 10.1016/S0929-7855(97)00013-8.

Cammer W, Tansey F, Abramovitz M, Ishigaki S, Listowsky I: Differential localization of glutathione-S-transferase Yp and Yb subunits in oligodendrocytes and astrocytes of rat brain. J Neurochem. 1989, 52: 876-883. 10.1111/j.1471-4159.1989.tb02536.x.

Philbert MA, Beiswanger CM, Manson MM, Green JA, Novak RF, Primiano T, Reuhl KR, Lowndes HE: Glutathione S-transferases and gamma-glutamyl transpeptidase in the rat nervous systems: a basis for differential susceptibility to neurotoxicants. NeuroToxicology. 1995, 16: 349-362.

Johnson JA, el Barbary A, Kornguth SE, Brugge JF, Siegel FL: Glutathione S-transferase isoenzymes in rat brain neurons and glia. J Neurosci. 1993, 13: 2013-2023.

Senjo M, Ishibashi T, Terashima T, Inoue Y: Successive appearance of glutathione S-transferase-positive cells in developing rat brain: choroid plexus, pia mater, ventricular zone and astrocytes. Neurosci Lett. 1986, 66: 131-134. 10.1016/0304-3940(86)90178-3.

Carder PJ, Hume R, Fryer AA, Strange RC, Lauder J, Bell JE: Glutathione S-transferase in human brain. Neuropathol Appl Neurobiol. 1990, 16: 293-303. 10.1111/j.1365-2990.1990.tb01264.x.

Anderson ME, Underwood M, Bridges RJ, Meister A: Glutathione metabolism at the blood-cerebrospinal fluid barrier. FASEB J. 1989, 3: 2527-2531.

Johansson K, Ahlen K, Rinaldi R, Sahlander K, Siritantikorn A, Morgenstern R: Microsomal glutathione transferase 1 in anticancer drug resistance. Carcinogenesis. 2007, 28: 465-470.

Shi J, Karlsson HL, Johansson K, Gogvadze V, Xiao L, Li J, Burks T, Garcia-Bennett A, Uheida A, Muhammed M: Microsomal glutathione transferase 1 protects against toxicity induced by silica nanoparticles but not by zinc oxide nanoparticles. ACS Nano. 2012, 6: 1925-1938. 10.1021/nn2021056.

Toppo S, Flohe L, Ursini F, Vanin S, Maiorino M: Catalytic mechanisms and specificities of glutathione peroxidases: variations of a basic scheme. Biochim Biophys Acta. 2009, 1790: 1486-1500. 10.1016/j.bbagen.2009.04.007.

Tayarani I, Cloez I, Clement M, Bourre JM: Antioxidant enzymes and related trace elements in aging brain capillaries and choroid plexus. J Neurochem. 1989, 53: 817-824. 10.1111/j.1471-4159.1989.tb11778.x.

Nardacci R, Falciatori I, Moreno S, Stefanini S: Immunohistochemical localization of peroxisomal enzymes during rat embryonic development. J Histochem Cytochem. 2004, 52: 423-436. 10.1177/002215540405200401.

Kitamura Y, Ishida Y, Takata K, Mizutani H, Kakimura J, Inden M, Nakata J, Taniguchi T, Tsukahara T, Akaike A: Hyperbilirubinemia protects against focal ischemia in rats. J Neurosci Res. 2003, 71: 544-550. 10.1002/jnr.10514.

Sutherland BA, Rahman RM, Clarkson AN, Shaw OM, Nair SM, Appleton I: Cerebral heme oxygenase 1 and 2 spatial distribution is modulated following injury from hypoxia-ischemia and middle cerebral artery occlusion in rats. Neurosci Res. 2009, 65: 326-334. 10.1016/j.neures.2009.08.007.

Yamaguchi T, Komoda Y, Nakajima H: Biliverdin-IX alpha reductase and biliverdin-IX beta reductase from human liver. Purification and characterization. J Biol Chem. 1994, 269: 24343-24348.

Mathieu MC, Lapierre I, Brault K, Raymond M: Aromatic hydrocarbon receptor (AhR).AhR nuclear translocator- and p53-mediated induction of the murine multidrug resistance mdr1 gene by 3-methylcholanthrene and benzo(a)pyrene in hepatoma cells. J Biol Chem. 2001, 276: 4819-4827. 10.1074/jbc.M008495200.

Leininger-Muller B, Ghersi-Egea JF, Siest G, Minn A: Induction and immunological characterization of the uridine diphosphate-glucuronosyltransferase conjugating 1-naphthol in the rat choroid plexus. Neurosci Lett. 1994, 175: 37-40. 10.1016/0304-3940(94)91072-3.

Tolson AH, Wang H: Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev. 2010, 62: 1238-1249. 10.1016/j.addr.2010.08.006.

Lindvall M, Hardebo JE, Owman C: Barrier mechanisms for neutrotransmitter monoamines in the choroid plexus. Acta Physiol Scand. 1980, 108: 215-221. 10.1111/j.1748-1716.1980.tb06525.x.

Kurogi K, Alazizi A, Liu MY, Sakakibara Y, Suiko M, Sugahara T, Liu MC: Concerted actions of the catechol O-methyltransferase and the cytosolic sulfotransferase SULT1A3 in the metabolism of catecholic drugs. Biochem Pharmacol. 2012, 84: 1186-1195. 10.1016/j.bcp.2012.08.009.

Saunders NR, Liddelow SA, Dziegielewska KM: Barrier mechanisms in the developing brain. Front Pharmacol. 2012, 3: 46-

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả